OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
June 21, 2021
The root cause of the most serious integrity issues has generally been a lapse of ethical behavior on the part of an individual.
June 02, 2021
GSK’s position is raising concerns as it continues working towards its separation of businesses.
Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates.
Technology advances foster new therapies.
May 02, 2021
As face masks start to come off, bio/pharma’s COVID-19 battle goes on.
The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.
April 02, 2021
COVID-19 has placed bio/pharma in the spotlight of global media, but away from vaccines there are other prospective pipeline treatments that will be worth watching.
March 02, 2021
Bio/pharma works hard today to change the calendar to tomorrow.
More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.
February 02, 2021
More work is needed to educate businesses on the value of innovation and the availability of funding.